The yeast target of rapamycin (Tor) kinases, Tor1 and Tor2, belong to the phosphatidylinositol 3-kinase-related family of proteins, which are involved in the cellular response to DNA damage and changes in nutrient conditions. In contrast to yeast, many eukaryotes possess a single Tor kinase. Regardless of the number of Tor kinases in an organism, two distinct complexes involving Tor proteins exist in eukaryotes, TORC1 and TORC2. The yeast TORC1, containing Tor1 or Tor2, is sensitive to the antibiotic rapamycin. The yeast TORC2 is insensitive to rapamycin. We examined the influence of rapamycin treatment upon yeast transcription-coupled nucleotide excision repair in a gene transcribed by RNA polymerase II. We also examined tor mutants for their ability to perform transcription-coupled repair in the absence or presence of rapamycin. Ostensibly lacking TORC1 and TORC2 function, a tor1tor2 ts mutant grown at the nonpermissive temperature exhibited similar rates of repair as the wild-type strain. However, repair of both strands in genes decreases in the wild-type strain and the tor1tor2 ts mutant exposed to rapamycin. Rapamycin may be inhibiting DNA repair independently of the Tor kinases. In yeast, FPR1 encodes the rapamycin-binding protein Fpr1 that inhibits the TORC1 kinase in the presence of rapamycin. Fap1 competes with rapamycin for Fpr1 binding. Deletion of the FPR1 or FAP1 gene abolishes the inhibitory effect of rapamycin on repair. Thus, the decreased repair observed following rapamycin treatment is independent of TORC1/2 function and likely due to a function of Fap1. We suggest that Fap1 and peptidyl-prolyl isomerases, particularly Fpr1, function in the cellular response to genotoxic stress. Our findings have clinical implications for genetic toxicities associated with genotoxic agents when coadministered with rapamycin.
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The conserved phosphatidylinositol 3-kinase (PI3K)-related family of proteins is involved in cellular responses to extracellular conditions and DNA damage. Members of the family include ATM (a gene mutated in the disease ataxia telangiectasia), DNA-PKcs (the catalytic subunit of the DNAdependent protein kinase), Mec1, Tel1, and Rad3 (Hoekstra, 1997) . Another group of PI3K-related proteins, the mammalian and yeast target of rapamycin (Tor) kinases, are involved in cell growth control and nutrient sensing (Schmelzle and Hall, 2000) . The Tor proteins, encoded by TOR1 and TOR2, were first discovered in yeast as the targets of rapamycin, an immunosuppressant agent that inhibits T-cell proliferation in mammalian cells via mechanisms elucidated in yeast (Heitman et al., 1991) . The Tor proteins exist in two distinct protein complexes, TORC1 and TORC2 (De Virgilio and Loewith, 2006) . TORC1 can contain Tor1 or Tor2 and is sensitive to rapamycin. TORC2 contains only Tor2 and is insensitive to rapamycin. When rapamycin is bound to its target in yeast, the peptidyl-prolyl isomerase Fpr1, the Fpr1-rapamycin complex inhibits the kinase activity of the TORC1 complex. Alteration of the rapamycin-binding site of Fpr1, or the Fpr1-rapamycinbinding site in Tor proteins, confers resistance to rapamycin (Lorenz and Heitman, 1995; Zaragoza et al., 1998) .
In a genetic screen for genes encoding dosage suppressors of rapamycin toxicity, FAP1 was identified and characterized as encoding an Fpr1-associated protein (Kunz et al., 2000) . Fap1 is a homolog of the human transcriptional repressor NF-X1, which is involved in the regulation of major histocompatibility genes during the inflammatory response (Kunz et al., 2000; Song et al., 1994) . The interaction of Fap1 with Fpr1 is competitively disrupted by the addition of rapamycin (Alarcon and Heitman, 1997; Dolinski and Heitman, 1999; Kunz et al., 2000) . Thus, the effects of rapamycin can also be attributed to the release of Fap1 or other factors from Fpr1 that subsequently affect transcription.
Tor1 and Tor2, as part of TORC1, function in the cellular response to nutrient conditions or stress via translational and transcriptional control and can be blocked by rapamycin (Rohde et al., 2001; Schmelzle and Hall, 2000) . The TORC1 pathway coordinates aspects of ribosome biogenesis, such as ribosomal RNA (rRNA) synthesis by RNA polymerase (RNA pol) I, processing of the 35S rRNA precursor, and regulation of ribosomal protein gene expression by RNA pol II (Kuruvilla et al., 2001; Powers and Walter, 1999; Raught et al., 2001) . The mammalian Tor (mTor) kinases have been implicated as signal transduction components that respond to DNA damage to induce cytokine gene expression in normal human epidermal keratinocytes, and Tor kinases are regulated in a p53-dependent manner (Budanov and Karin, 2008; Yarosh et al., 2000) .
A highly conserved mechanism of DNA repair in eukaryotes is nucleotide excision repair (NER), which removes bulky DNA adducts such as cyclobutane pyrimidine dimers (CPDs) induced by ultraviolet (UV) radiation (Friedberg et al., 1995) . In genes actively transcribed by RNA pol II, CPDs are removed from the transcribed strand faster than the nontranscribed strand in a process known as transcription-coupled DNA repair (TCR), a subpathway of NER. The level of repair in the nontranscribed strand is similar to repair of the entire genome, a process known as global genomic repair. We examined if rapamycin treatment impacts the Tor signaling pathway, or other components associated with Tor (such as Fpr1 or Fap1), to affect the cellular response to DNA damage as shown for other members of the PI3K family.
MATERIALS AND METHODS
Strains, media, and growth. All strains were kindly provided by M. N. Hall (University of Basel, Basel, Switzerland): JK9-3da (wild-type parental strain: MATa leu2-3, 112 ura3-52 rme1 trp1 his4 GAL þ HMLa), MH349-3d (same as parental, tor1::LEU2-4), SH121 (same as parental, tor2::ADE2-3/ YCplac111::tor2-21ts), SH221 (same as parental, tor1::HIS3-3 tor2::ADE2-3/ YCplac111::tor2-21ts), JHY1-2c (same as parental, fpr1::URA3-1), and MH347-2D (same as parental, fap1::LEU2-2). Synthetic dextrose (SD) is minimal media (0.17% yeast nitrogen base, 0.5% ammonium sulfate, and 2% glucose). Growth of strains was on SD supplemented with the appropriate amino acids. Rapamycin (Sigma, St. Louis, MO) was made 1 mg/ml in the vehicle (90% ethanol/10% Tween-20) and added to cultures at a final concentration of 0.2 lg/ml. Strains were grown overnight in minimal media supplemented with appropriate amino acids. Each strain was diluted 10-fold in fresh media and grown at 30°C, the permissive temperature for the conditional mutants, for 1 h prior to taking optical density (OD 600nm ) readings. The cultures either remained at 30°C or were shifted to 37°C, the nonpermissive temperature for the conditional mutants. The OD 600nm of each culture in different conditions was taken by spectrophotometer analysis over a period of 12 h. For treatment with 0.2 lg/ml of rapamycin, all strains were grown for 5 h to early log phase at 30°C prior to the addition of rapamycin or vehicle.
UV irradiation and strand-specific repair assay. The detailed protocol for the strand-specific repair assay in yeast was previously described (Sweder and Hanawalt, 1992) . Mid-logarithmic cultures were grown in SD supplemented with the appropriate amino acids and then collected by centrifugation. Cells were resuspended (~1.0 3 10 7 cells/ml) in PBS. Temperature-sensitive tor2 ts and tor1tor2 ts mutants were grown overnight at the permissive temperature, diluted 1:10 in fresh media, grown at the permissive temperature (30°C) for 1 h, and shifted to the nonpermissive temperature (37°C) for 5 h before UV irradiation. Additionally, wild-type, fpr1, fap1, and tor1tor2 ts strains were treated with 0.2 lg/ml rapamycin 1.75 h prior to UV irradiation and returned to their original medium throughout the remainder of the experiment.
Cells suspended in PBS were irradiated with predominantly 254 nm UV light at 60 J/m 2 using a germicidal lamp (American Ultraviolet Co., Lebanon, IN). To measure the initial incidence of DNA damage, an aliquot was taken immediately after the irradiation (0 min of repair) and prepared for cell lysis, while the remainder of the irradiated cells were collected by centrifugation and resuspended in the original media at the appropriate temperature to allow time for repair. Aliquots were taken at 15, 30, 60, and 90 min and prepared for cell lysis. Spheroplasts were made by adding Zymolyase 100T (ICN, Costa Mesa, CA) to digest the cell walls. The DNA was extracted, purified, and digested with a restriction endonuclease (HincII) resulting in fragments of 5.0 kb for RPB2.
After restriction digestion, DNA from each time point was ethanol precipitated, resuspended, and divided in half. One half was treated with the CPDspecific T4 endonuclease V (TEV), which makes a single-stranded break at the site of each CPD. Such strand breaks will reduce the amount of the full-length restriction fragments when electrophoresed under alkaline conditions. The other half was mock treated and used to quantify the amount of DNA extracted from each time point. The samples were denatured, electrophoresed through an alkaline agarose gel, and transferred onto nylon membranes (Hybond Nþ, GE Healthcare, Piscataway, NJ).
Using RNA probes specific for either the transcribed or the nontranscribed strand, it is possible to determine the rates and extent of repair for the individual strands of the gene of interest. The membranes were sequentially hybridized and exposed to x-ray film with one 32 P-radiolabeled RNA probe (as described below) at a time. Assuming a Poisson distribution of initial DNA damage, the number of CPDs per fragment can be calculated from the ratio of the hybridization signal intensities for the TEV-treated samples versus mock-treated controls as quantified with the application National Institutes of Health Image 1.62.
Plasmid construction and probes. For a gene transcribed by RNA pol II, an~1.0-kb fragment of RPB2 was previously cloned into the Bluescript pKSþ vector (Stratagene, La Jolla, CA), which has a T7 and T3 promoter flanking the insert as well as an EcoRI and XhoI restriction site at the opposite ends of the insert (Sweder and Hanawalt, 1992) . Plasmid pKS212 was linearized by cleaving with XhoI or EcoRI and incubated with (a-32 P) cytidine triphosphate (GE Healthcare, Piscataway, NJ), ribonucleotide triphosphates, and T7 RNA pol or T3 RNA pol, respectively, under conditions recommended by the manufacturer to generate strand-specific radioactive RNA probes (transcribed or nontranscribed strand, respectively) for RPB2 (Sweder and Hanawalt, 1992) .
Statistical analysis of repair. For each strain and experimental treatment condition, the initial rate of repair was estimated using a linear function to describe the relationship between %CPD values and time (0-30 min). A no-intercept model was utilized since values at time 0 were used to calculate subsequent %CPD values. The slope estimates were then compared to evaluate differences in initial rate of repair between rapamycin treatment and no treatment or between each mutant strain and wild type for each treatment condition. The treatment conditions are identified as rapamycin-transcribed and -nontranscribed strands and vehicle-transcribed and -nontranscribed strands in Figures 1B and 3 and 30°transcribed and 30°nontranscribed strands and 37°transcribed and 37°n ontranscribed strands in Figure 2 . In addition, for each strain, the slope estimates were compared to evaluate differences between treatment conditions: difference between temperature for each strand, differences between rapamycin treatment (þ RM vs. ÀRM) for each strand, and differences between strands (nontranscribed vs. transcribed) for each temperature or þ RM and ÀRM treatment. Comparisons were made at the 5% significance level. In addition, comparisons of mean %CPD were made at each time point (15-90 min). In the context of a one-way ANOVA model, separately by time and treatment condition, comparisons between the mean %CPD for mutant strains versus wildtype strain were made using t-tests. In a two-way ANOVA, separately by strain, comparisons within treatment conditions were made (transcribed vs. nontranscribed strands for each temperature [30°C and 37°C] or rapamycin treatment [þ RM and ÀRM] and temperature differences or rapamycin treatment differences for both transcribed and nontranscribed strands) using t-tests. Each t-test was evaluated at the 5% significance level.
RESULTS

Strand-Specific Repair of UV-Induced DNA Damage in the Wild Type Treated with Rapamycin
The Tor kinases have been implicated in the cellular response to DNA damage (Budanov and Karin, 2008; Yarosh 78 LIMSON AND SWEDER et al., 2000) . We measured repair in cells where Tor activity was repressed biochemically with rapamycin, a well-characterized inhibitor of the TORC1 kinase (Cardenas et al., 1999) . Cultures of the wild-type strain were grown in the absence or presence of 0.2 lg/ml rapamycin for 1.75 h prior to and after UV irradiation as described in ''Materials and Methods'' section. Representative autoradiograms of strand-specific repair assays for the RPB2 gene in the wild type grown at 30°C in the absence or presence of rapamycin are shown in Figure 1A . The ratio of the hybridization intensities in the TEV-treated DNA versus the mock-treated DNA samples increased faster for the transcribed strand than for the nontranscribed strand of RPB2 in the wildtype strain (Fig. 1A) . The number of CPDs removed was calculated (from the hybridization signal intensities from multiple experiments), and the percent repair over time for the RPB2 gene in the wild-type strain in the absence or presence of rapamycin are shown graphically in Figure 1B .
Linear slope estimates (0-30 min) were made based on a no-intercept model and were then compared to evaluate differences in initial rate of repair in the wild-type strain in FIG. 1. (A) Representative autoradiograms from strand-specific repair assays in RPB2 in the wild-type strain in the absence (top panel) or presence of rapamycin (bottom panel). Exponentially growing wild-type cultures at 30°C were sham treated or treated with rapamycin, were UV irradiated at 60 J/m 2 , and then incubated at the respective temperatures for the times indicated. DNA purified from the cells was digested with the restriction endonuclease HincII to generate a 5.0-kb fragment containing RPB2. Restricted DNA was digested with TEV (þ) or mock treated (À) and then electrophoresed through 0.5% alkaline agarose. DNA was transferred to Hybond Nþ membranes and sequentially hybridized with an RNA probe specific for either the transcribed or the nontranscribed strand of the RPB2 gene. (B) Rapamycin decreases repair of RPB2 after UV damage in a wild-type strain. Strand-specific repair after UV irradiation in wild-type cells grown at 30°C and treated with rapamycin (n) or vehicle (d) for 1.75 h. The average percent repair of the transcribed (---) and nontranscribed (---) strands is calculated from at least three repair experiments. Vertical bars at each point indicate SE of the mean.
DNA REPAIR INHIBITION BY RAPAMYCIN 79 the absence or presence of rapamycin. In the absence of rapamycin, the rate of repair of the transcribed strand is~3.5-fold faster than that of the nontranscribed strand (Fig. 1B) . In the presence of rapamycin, the rate of repair of the transcribed strand is~2.1-fold faster than that of the nontranscribed strand. By 90 min, repair reaches 80% with rapamycin versus 96% without treatment. Thus, there was a significant reduction in the rate of repair of the transcribed strand of RPB2 due to rapamycin treatment (p < 0.01). The level of repair in the nontranscribed strand in either gene is also reduced about 12% from 30 to 90 min following irradiation, although the rates of repair of the nontranscribed strands are not statistically different (p > 0.05). Thus, wild-type cells that were exposed to rapamycin showed a decrease in the rate of repair in the RPB2 gene.
Strand-Specific Repair of UV-Induced DNA Damage in tor Mutants
Having demonstrated a decrease in repair following treatment with the TORC1 inhibitor rapamycin, we next measured repair in cells where Tor activity was shut off genetically using deletion and/or conditional tor mutants. Cultures of the wildtype strain and the tor mutant strains at the permissive (30°C) and nonpermissive (37°C) temperatures were UV irradiated as described in ''Materials and Methods'' section.
For the RPB2 gene, the wild type and each mutant at 30°C and 37°C exhibit TCR where the transcribed strand is repaired faster than the nontranscribed strand (Fig. 2) . At 30°C, the transcribed strand in the wild-type strain is repaired~2.5-fold faster than the nontranscribed strand (p < 0.01). Similarly, at 37°C, repair of the transcribed strand is about 2.5-fold greater than that of the nontranscribed strand (p < 0.01). However, the rate of repair of the transcribed and the nontranscribed strands is significantly greater at 37°C than at 30°C with p < 0.01 and p < 0.05, respectively. The tor1 mutant displays repair rates similar to the wild-type strain with the exception that repair of the nontranscribed strand was not statistically elevated at 37°C compared to the repair observed at 30°C (Fig. 2) . Repair of RPB2 in the tor2 ts and tor1tor2 ts mutants, containing a single plasmid-borne copy of the same conditional allele of TOR2 (tor2-21), is similar to the repair observed in the wild-type and tor1 strains with some subtle differences. Repair of the transcribed strands is faster than that of the nontranscribed strands at 30°C and 37°C (p < 0.01 and p < 0.01, respectively). Interestingly, the initial repair rates of the transcribed strand in the tor2 ts and tor1tor2 ts mutants at both 30°C and 37°C were intermediate between the repair observed in the wild-type and tor1 strains at 30°C and 37°C. Consequently, the significantly faster repair of the transcribed strand at 37°C relative to repair at 30°C seen in wild-type and tor1 (Fig. 2 ) strains is not apparent (i.e., significant) in the tor2 ts and tor1tor2 ts (Fig. 2) . As in the tor1 mutant, there is no significant change in repair of the nontranscribed strand of RPB2 at 37°C compared to 30°C in either the tor2 ts or the tor1tor2 ts double mutant.
Strand-Specific Repair of UV-Induced DNA Damage in the tor1tor2 ts Mutant at the Nonpermissive Temperature Treated with Rapamycin
The minimal differences in repair between the wild-type and tor mutant strains lead us to directly test whether or not rapamycin may inhibit repair independently of Tor1 or Tor2. When the tor1tor2 ts mutant, growing at the nonpermissive temperature for 3.25 h and lacking TORC1 and TORC2 activity, was treated with 0.2 lg/ml rapamycin for an additional 1.75 h, repair of both strands in the RPB2 gene surprisingly decreased (Fig. 3) . In the RPB2 gene, the rate of repair of the transcribed strand is very rapid over the first 30-min postirradiation and significantly faster than repair of the nontranscribed strand over the same period (p < 0.05). Under the same conditions and in the presence of rapamycin, the rate of repair of the transcribed strand is reduced significantly (p < 0.05) relative to repair in the absence of rapamycin. Strikingly, repair rates for the nontranscribed strand in the presence of rapamycin were also greatly diminished relative to repair rates in the absence of rapamycin (p < 0.01). As described above in the experiments measuring repair in the tor1tor2 ts mutant at the nonpermissive and permissive temperatures, repair of the nontranscribed strand of RPB2 in tor1tor2 ts is not affected by a temperature shift. Thus, repair in both strands of RPB2 is significantly reduced in the tor1tor2 ts mutant treated with rapamycin and grown at the nonpermissive temperature and lacking TORC1/2 activity.
Strand-Specific Repair of UV-Induced DNA Damage in an fpr1 Mutant
In order to determine how the inhibitory effect of rapamycin occurs, we examined repair in mutants lacking a rapamycin- binding   FIG. 3 . Rapamycin decreases repair of RPB2 after UV damage in a tor1tor2 ts mutant but not in an fpr1 or fap1 mutant. Strand-specific repair after UV irradiation in (A) fpr1 mutant grown at 30°C and treated with rapamycin (n) or vehicle (h) for 1.75 h, (B) fap1 mutants grown at 30°C and treated with rapamycin (¤) or vehicle (e) for 1.75 h, and (C) tor1tor2 ts mutants grown at 37°C and treated with rapamycin (n) or vehicle (:) for 1.75 h. The average percent repair of the transcribed (---) and nontranscribed (---) strands is calculated from at least three repair experiments. Vertical bars at each point indicate SE of the mean. The dashed lines lacking symbols in (A and B) represent repair of the transcribed strand in the wild-type strain treated with rapamycin (see Fig. 1B We first determined if disruption of the FPR1 gene influences the rates and extent of NER in UV-irradiated cells. Cultures of the fpr1 mutant strain were mock treated or treated with rapamycin prior to UV irradiation and during the time allowed for repair. In the rapamycin-resistant fpr1 mutant, rapamycin does not significantly affect the repair of either strand in RPB2 (Fig. 3) . In the presence or absence of rapamycin, repair in the transcribed strand of RPB2 is not significantly different than the wild type without rapamycin (p > 0.05) but is greater than the repair in the rapamycin-treated wild-type strain (p < 0.05).
In the presence or absence of rapamycin, the rate of repair in the nontranscribed strand of RPB2 in fpr1 is also not significantly different than the wild type in the presence or absence of rapamycin (Figs. 1B and 3 ). In the presence of rapamycin, the level of repair in the nontranscribed strand in an fpr1 mutant approximates that of the nontranscribed strand of RPB2 in the wild type treated with rapamycin (p > 0.05). Similarly, in the absence of rapamycin, repair in the nontranscribed strand of RPB2 in fpr1 is not significantly different than that of the wild type treated with rapamycin (p > 0.05).
Strand-Specific Repair of UV-Induced DNA Damage in a fap1 Mutant Following release from Fpr1, Fap1 may function as a transcriptional repressor, like its mammalian homolog, to inhibit transcription and thereby inhibit TCR. Such an indirect effect on TCR can be measured in our assay by using a fap1 mutant. In a fap1 mutant, transcription of genes inhibited by Fap1 would not be repressed. Thus, rapamycin treatment in a fap1 mutant should not affect the inhibition of repair normally caused by Fap1. However, rapamycin bound to Fpr1 in a fap1 mutant will still inhibit the TORC1 activity regulating transcription (N.B. fap1 disruption mutants are as rapamycin sensitive as the wild-type parental strain; Kunz et al., 2000) . Thus, the inhibition of transcription that is indirectly measured by repair would be reflected in a similar rate of repair between an fap1 mutant and an fpr1 mutant.
Cultures of the fap1 mutant strain were mock treated or treated with rapamycin, irradiated with UV light, and allowed time for repair. There is little or no difference in the level of repair of either strand in RPB2 after UV damage when fap1 is treated with rapamycin or mock treated (Fig. 3) . Although the initial rate of repair of the nontranscribed strand in the fap1 mutant without rapamycin is initially less than that when treated with rapamycin (p < 0.05), the nontranscribed strands from both conditions reach only about 45% repair by 90 min (Fig. 3) . Repair rates of the transcribed strand in the first 30 min in the presence or absence of rapamycin are not significantly different (p > 0.05) and are similar to the repair in the transcribed strand in the wild type without rapamycin (p > 0.05). In contrast, repair rates of the transcribed strand in the presence of rapamycin are significantly different than that for the transcribed strand in the wild-type strain treated with rapamycin (p < 0.01). Additionally, at later time points, the level of repair in the fap1 mutant is approximately equal to the level of repair in the fpr1 mutant treated with rapamycin or not, reaching about 80% by 90 min. Thus, rapamycin does not affect the rate of repair for RPB2 in a fap1 mutant, which has an overall rate of repair in RPB2 near that of the wild type and fpr1 mutant.
DISCUSSION
We examined the effect of rapamycin treatment upon strandspecific repair of UV-induced damage in a gene transcribed by RNA pol II in a repair-proficient Saccharomyces cerevisiae strain. By treating yeast with rapamycin, we observed a decrease in TCR. Like most laboratory strains, the parental strain JK9-3da exhibits classical TCR in which the transcribed strand of class II genes is repaired faster than the nontranscribed strand. In the presence of rapamycin repair rates of the transcribed strand of RPB2 were significantly reduced, and repair rates of the nontranscribed strand were slightly reduced. Though rapamycin inhibits ribosomal protein gene transcription by RNA pol II, other genes transcribed by RNA pol II are not repressed (Hardwick et al., 1999; Shamji et al., 2000) . Thus, the effect on TCR within the RPB2 gene is not a direct inhibition of transcription. Additionally, we do not think that the effect of rapamycin on TCR in wild-type cells simply reflects the inhibitory effect of rapamycin on cell growth. We and others have published data demonstrating that cultures that have been arrested in the cell cycle due to cycloheximide treatment, temperature-sensitive mutants, or hydroxyurea treatment have no deficit in TCR related to untreated samples (Conconi et al., 2002; Lommel et al., 2000; Sweder and Hanawalt, 1992) .
Having shown that rapamycin inhibits the repair rate of transcribed strands, we then examined whether or not this inhibition was mediated through the Tor signaling pathway. We inhibited Tor kinase activity genetically, by using yeast mutants containing a disrupted TOR1 allele or a conditional temperaturesensitive TOR2 allele or both. At the nonpermissive temperature (37°C), tor1tor2 ts mutants lack both TORC1 and TORC2 kinase activities. We found increased repair of RPB2 in the wild-type strain at 37°C relative to 30°C, consistent with increased rates for cellular processes at higher temperatures. We found subtle differences in the rates of repair among the tor1, tor2 ts , and tor1tor2 ts mutants at the permissive and nonpermissive temperatures, but these differences were not statistically significant relative to the wild-type strain. Additionally, we observed an unambiguous inhibition of repair at the nonpermissive 82 LIMSON AND SWEDER temperature when the tor1tor2 ts strain was treated with rapamycin prior to and during the time of repair. Rapamycinresistant mutants TOR1-1 and TOR2-1 also showed marked reduction of repair in the presence of rapamycin (data not shown). We conclude that the rapamycin-induced inhibition of repair is not a result of Tor kinase activity inhibition.
In addition to inhibiting Tor kinase activity, rapamycin treatment causes Fpr1 to release factors that have the potential to affect transcription and/or affect repair, such as Fap1. Therefore, we examined repair of fpr1 and fap1 disruption mutants in the absence or presence of rapamycin. Unlike the wild-type strain, where rapamycin treatment reduced repair of the transcribed strand significantly, the overall levels of repair for both strands of the gene examined in the rapamycin-resistant fpr1 mutant and the fap1 mutant, treated or not with rapamycin, are similar to the levels of repair observed in the wild-type strain in the absence of rapamycin. That Fpr1 associates with Fap1 in the absence of rapamycin may provide an explanation for this observation (Kunz et al., 2000) . In the presence of rapamycin, the cytoplasmic Fpr1 binds to rapamycin and is sequestered from its functional interaction with Fap1. Fap1 then relocates to the nucleus and interacts with DNA as a putative transcriptional repressor for as yet unidentified genes (Kunz et al., 2000) . Simultaneously, the Fpr1-rapamycin complex inhibits TORC1 activity and affects transcriptional regulation of other genes.
In the rapamycin-resistant fpr1 mutant, rapamycin is neither able to inhibit the TORC1 complex nor regulate factors associated with Fpr1. In this case, Fap1 is not bound to Fpr1. However, Fap1 has been observed to remain in the cytoplasm in cells lacking Fpr1 (Kunz et al., 2000) . In the fap1 mutant, Fap1 is not available to repress transcription (or as yet unknown functions) in the presence or absence of rapamycin, despite being as rapamycin sensitive as the wild-type parental strain (recall that the fap1 mutant still possesses functional Fpr1 protein that can bind rapamycin and inhibit Tor activity). Thus, in either mutant, wild-type levels of repair were observed. The decrease of repair in RPB2 observed after rapamycin treatment in the wild-type strain led us to conclude that the control of the NER response regulated by rapamycin is twofold. First, repression of TCR is not due to the inhibition of Tor regulation. Second, rapamycin competitively releases factors interacting with Fpr1 that subsequently repress TCR.
Another likely candidate that interacts with Fpr1 and competes with rapamycin is Hmo1, a HMG protein in yeast (Dolinski and Heitman, 1999; Lu et al., 1996) . As a chromatinassociated HMG-like protein, Hmo1 binds DNA by structure rather than sequence specificity. As Cardenas et al. (1999) suggested, Fpr1 might regulate the assembly of Hmo1 complexes or Hmo1-DNA interactions. The same phenotype may exist in the absence of Fpr1, as in the fpr1 mutant, where Hmo1 can oligomerize and affect DNA repair mechanisms. Perhaps, Fpr1 may have other unidentified associated factors that may contribute to regulating TCR and interfere with the cellular response to DNA damage.
In summary, we expected that conditional mutants lacking Tor function would behave like rapamycin-treated cells with respect to repair deficiencies. Instead, we observed repair rates of a class II gene in tor1tor2 ts (and in the other tor mutants) similar to repair rates in the wild-type strain. In contrast, rapamycin treatment of the wild-type strain and the tor1tor2 ts mutant reduced NER, indicating that rapamycin was affecting a factor other than the TORC complexes. We suspected the rapamycin-binding protein Fpr1, and/or factors associated with Fpr1, may indirectly inhibit repair by affecting transcription independently of the Tor pathway. Fpr1 may have a role in regulating DNA-binding proteins, such as Fap1 and Hmo1, which may contribute to regulating transcriptional activity or DNA accessibility. In the presence of rapamycin, these factors are competitively released from Fpr1 and affect transcription or the DNA damage response pathway in a manner yet to be determined and subsequently affect DNA repair.
The findings reported here have important implications for clinical applications of inhibitors of mTor, like rapamycin. Coadministration of mTor inhibitors with genotoxic agents, as in an oncology indication, will likely result in greater amounts of DNA damage persisting into S phase such that DNA replication will fix the damage into mutations or cell death may occur. While such outcomes may result in tumor regression, enhanced mutagenesis in normal tissues will likely increase carcinogenesis in the long term. 
